In light of the extensive number of cellular systems in which cellular senescence has been studied, therapies that induce senescence as part of their anti-cancer effects, such as cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors [15,16,17,18,19,20], will be used to illustrate key concepts and functional connections. Here, CDK4 is linked to cancer.